Newspaper (Reporter Li Yunming) February 23，Guangyao Group held the "Twelfth Five -Year Plan" development strategy and planning implementation mobilization meeting，Outline of "Outline of the Twelfth Five -Year Development Strategy and Planning of Guangyao Group" and the key work of Guangyao Group in 2011。

 

According to the "Twelfth Five -Year Plan" plan in accordance with Guangyao Group: By 2013, the sales scale was 45 billion yuan，Squeeze into the top four of my country's pharmaceutical manufacturing industry，Enter the top 10 of the top 100 manufacturing enterprises in Guangdong Province; by 2015, it will realize the sales revenue of industrial and commercial sales of more than 60 billion yuan，Become the largest pharmaceutical scale in China、The most My stake betting appstake sports betting appcomplete industrial chain、Marketing Network is the most sound、One of the most powerful comprehensive pharmaceutical enterprise groups with the strongest research and development strength; by 2020, it will achieve 150 billion yuan in industrial and commercial sales income，Become a Chinese medicine、Chemical drugs and biopharmaceuticals are representative "Danan Pharmaceutical King"，Become a world -class pharmaceutical research and development、Manufacturing、One of the Fortune 500 companies in the medical circulation。

 

The reporter also learned，At present, the internationalization of Guangyao Group is accelerating，In addition to Hehe Yellow、Best and other national strategic partners to form a strategic alliance，2010 Cantonese Pharmaceutical stake sports betting appstake betting appGroup has taken the lead in entering Russia's "Basic Medicine Catalog" with Qi Xing Huayu Reinforcement Pills，Signing with Belarus Cardiovascular and Cerebrovascular Disease Diagnosis and Treatment and Drug Research Center，Joint establishment of "Guangyao Group Cardiovascular Cerebral Vascular Traditional Chinese Medicine International (CIS) Research Center"。